Soligenix, Inc. (SNGX) Stock Price, News, Quote & History - Yahoo Finance (2024)

0&&s)if(o){var r,a=(r=e.newCount)>99;s.textContent=a?"99+":r+"",null===(t=s.parentElement)||void 0===t||t.classList.add(zt)}else s.style.display="block"},f=function(){d.refreshPanel().then(h).then(ee).catch((function(){}))};e.addEventListener("close-all-menus",(function(){xe(c)||u()})),c&&(f(),setInterval((function(){f()}),3e5),o?l&&l.addEventListener("mouseenter",(function(){p(),null==t||t.show()})):c.addEventListener("mouseenter",(function(){p(),null==t||t.show()})),c.addEventListener("mouseleave",(function(){u(),null==t||t.hide()}))),e.addElementListener(i,"click",(function(){Q("ybar","notification","",{elm:"btn",elmt:"block"===(null==s?void 0:s.style.display)?"newalert":"",subsec:"notification",itc:"1"})})),r&&Ee(e,r,"ybar","notification",{elm:"expand",subsec:"notifications",itc:"2"}),e.addElementListener(a,"focusin",(function(){i&&(i.checked=!0),null==a||a.classList.add("ybarMenuOpen")})),e.addElementListener(a,"focusout",u),e.addElementListener(n.tooltipContainer,"focusin",(function(){null==t||t.show()})),e.addElementListener(n.tooltipContainer,"focusout",(function(){null==t||t.hide()}));var m=e.getConfig().device,v=document.getElementById("ybar");v&&v.classList.contains("ybar-ytheme-crunch")&&(eo=0);var y=new RegExp("[?&]notifications=1(&|#|$)");"desktop"===m&&i&&y.test(window.location.search)&&(i.checked=!0)};ye("ybar-mod-notification",(function(e){var n={isUH3:"crunch"===e.getConfig().ytheme,notifContainer:document.getElementById("notification-container"),notifBadge:document.getElementById("notif-badge"),notifMenu:document.getElementById("ybarNotificationMenu"),notifMenuOpener:document.querySelector("#ybarNotificationMenu + label"),notifDropdown:document.getElementById("notifDropdownContainer"),tooltipContainer:document.querySelector(".".concat(Gt)),notifLabel:document.querySelector(".".concat(Wt))};to(e,n)}))}()}};

NasdaqCM - Delayed Quote • USD

Compare

4.2400 +0.4200 (+10.99%)

At close: June 18 at 4:00 PM EDT

4.1900 -0.05 (-1.18%)

After hours: June 18 at 7:29 PM EDT

Key Events

Line

Candle

Baseline

Mountain

Bar

Advanced Chart

Loading Chart for SNGX

9/21 12:03 PM

DELL

Date
Close
Open
High
Low
Volume

• Previous Close 3.8200
• Open 3.8100
• Bid 3.9800 x 100
• Ask 4.3300 x 100
• Day's Range 3.8100 - 4.2800
• 52 Week Range 3.3000 - 32.0000
• Volume 87,489
• Avg. Volume 189,951
• Market Cap (intraday) 4.187M
• Beta (5Y Monthly) 1.93
• PE Ratio (TTM) --
• EPS (TTM) -9.7600
• Earnings Date Aug 19, 2024 - Aug 23, 2024
• Forward Dividend & Yield --
• Ex-Dividend Date --
• 1y Target Est 40.00

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX302, an IDR technology which is in Phase IIa study to treat mil-to-moderate Psoriasis; and SGX945 and IDR technology that is in Phase IIa protocol for the treatment of Aphthous Ulcers in Behçet's Disease. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia, Ib, and Ic clinical trials; SGX943, a therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.

www.soligenix.com

13

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Soligenix, Inc.

Recent News: SNGX

View More

All SEC Filings

Corporate Changes & Voting Matters

Periodic Financial Reports

Proxy Statements

Tender Offer/Acquisition Reports

Offering Registrations

See Also

Soligenix, Inc. (SNGX) Stock Historical Prices & Data - Yahoo FinanceSoligenix, Inc. Common Stock (SNGX) Stock Price & News - Google FinanceSoligenix, Inc. (SNGX) Latest Stock News & Headlines - Yahoo FinanceSoligenix, Inc. (SNGX) Stock Price, Quote & News - Stock Analysis

View More

Performance Overview: SNGX

Trailing total returns as of 6/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SNGX

65.13%

S&P 500

15.04%

1-Year Return

SNGX

61.59%

S&P 500

24.43%

3-Year Return

SNGX

98.53%

S&P 500

29.97%

5-Year Return

SNGX

97.55%

S&P 500

89.88%

Compare To: SNGX

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

SNGXSoligenix, Inc.

4.2400

+10.99%

Mkt Cap 4.187M

Industry Biotechnology

CANFCan-Fite BioPharma Ltd.

2.7300

-14.95%

Mkt Cap 14.471M

Industry Biotechnology

CNSPCNS Pharmaceuticals, Inc.

2.4200

-16.55%

Mkt Cap 947,766

Industry Biotechnology

LIXTLixte Biotechnology Holdings, Inc.

2.4700

-0.40%

Mkt Cap 5.556M

Industry Biotechnology

DRMADermata Therapeutics, Inc.

2.4800

-4.98%

Mkt Cap 1.394M

Industry Biotechnology

BPTHBio-Path Holdings, Inc.

2.2700

-5.02%

Mkt Cap 4.722M

Industry Biotechnology

See Also

Soligenix Inc Stock Price and Quote

THARTharimmune, Inc.

2.9650

-3.73%

Mkt Cap 2.331M

Industry Biotechnology

CEROCERo Therapeutics Holdings, Inc.

0.3140

-10.29%

Mkt Cap 4.73M

Industry Biotechnology

CLDICalidi Biotherapeutics, Inc.

0.1970

+1.03%

Mkt Cap 12.646M

Industry Biotechnology

ONCOOnconetix, Inc.

0.1531

-4.13%

Mkt Cap 3.418M

Industry Biotechnology

GOVXGeoVax Labs, Inc.

1.9000

+69.64%

Mkt Cap 4.804M

Industry Biotechnology

Statistics: SNGX

View More

Valuation Measures

Annual

As of 6/18/2024

• Market Cap

  4.19M

• Enterprise Value

  295.81k

• Trailing P/E

  --

• Forward P/E

  --

• PEG Ratio (5yr expected)

  --

• Price/Sales (ttm)

  --

• Price/Book (mrq)

  5.45

• Enterprise Value/Revenue

  1.87

• Enterprise Value/EBITDA

  --

Financial Highlights

Profitability and Income Statement

• Profit Margin

  0.00%

• Return on Assets (ttm)

  -50.00%

• Return on Equity (ttm)

  --

• Revenue (ttm)

  699.21k

• Net Income Avi to Common (ttm)

  -7.01M

• Diluted EPS (ttm)

  -9.7600

Balance Sheet and Cash Flow

• Total Cash (mrq)

  7.09M

• Total Debt/Equity (mrq)

  416.52%

• Levered Free Cash Flow (ttm)

  -5.64M

View More

Research Analysis: SNGX

View More

View More

Company Insights: SNGX

Research Reports: SNGX

View More

View More

People Also Watch

TENX Tenax Therapeutics, Inc.

3.0900

-0.32%

MBRX Moleculin Biotech, Inc.

3.9800

-1.00%

OPGN OpGen, Inc.

2.5300

+2.43%

PHIO Phio Pharmaceuticals Corp.

0.7129

+0.34%

VTVT vTv Therapeutics Inc.

18.78

-7.21%

HOTH Hoth Therapeutics, Inc.

0.9100

0.00%

PULM Pulmatrix, Inc.

1.9200

-2.54%

SNOA Sonoma Pharmaceuticals, Inc.

0.1920

+13.95%

CAPR Capricor Therapeutics, Inc.

4.8400

-2.42%

VTGN Vistagen Therapeutics, Inc.

3.3100

-3.22%

CLRB Cellectar Biosciences, Inc.

2.6700

-7.93%

DARE Daré Bioscience, Inc.

0.4300

-1.13%

CYCC Cyclacel Pharmaceuticals, Inc.

1.5000

-7.98%

XBIO Xenetic Biosciences, Inc.

3.9900

-4.55%

CTXR Citius Pharmaceuticals, Inc.

0.6106

-0.91%

NBY NovaBay Pharmaceuticals, Inc.

2.3000

-10.51%